In Reply II-Prescribing More Stringent Design of Randomized Clinical Trials of Omega-3 Polyunsaturated Fatty Acids

Affiliations

¹ Saint Luke's Mid America Heart Institute and University of Missouri-Kansas City, Kansas City, MO.
² John Ochsner Heart and Vascular Institute, Ochsner Clinical School-The University of Queensland School of Medicine, New Orleans, LA.

Comment

James H O'Keefe et al. Mayo Clin Proc. 2017 Jun.

. 2017 Jun;92(6):1007-1008.

doi: 10.1016/j.mayocp.2017.03.018.

¹ Saint Luke's Mid America Heart Institute and University of Missouri-Kansas City, Kansas City, MO.
² John Ochsner Heart and Vascular Institute, Ochsner Clinical School-The University of Queensland School of Medicine, New Orleans, LA.

No abstract available

Comment on

Omega-3 Fatty Acid Therapy: The Tide Turns for a Fish Story.
O'Keefe JH, Jacob D, Lavie CJ. O'Keefe JH, et al. Mayo Clin Proc. 2017 Jan;92(1):1-3. doi: 10.1016/j.mayocp.2016.11.008. Mayo Clin Proc. 2017. PMID: 28062059 No abstract available.
Prescribing More Stringent Design of Randomized Clinical Trials of Omega-3 Polyunsaturated Fatty Acids.
McLennan PL, Pepe S. McLennan PL, et al. Mayo Clin Proc. 2017 Jun;92(6):1005-1006. doi: 10.1016/j.mayocp.2017.03.019. Mayo Clin Proc. 2017. PMID: 28578776 No abstract available.